Molecular basis of differential 3′ splice site sensitivity to anti-tumor drugs targeting U2 snRNP

Abstract

Several families of natural compounds target core components of the pre-mRNA splicing machinery and display anti-tumor activity. Here the authors show that particular sequence features can be linked to drug response, and that drugs with very similar chemical structures display substantially different effects on splicing regulation.